Revolution Medicines (NASDAQ:RVMD) is preparing to release its quarterly earnings on Wednesday, 2026-02-25. Here’s a brief overview of what investors should keep in mind before the announcement.
Analysts expect Revolution Medicines to report an earnings per share (EPS) of $-1.56.
The market awaits Revolution Medicines’s announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It’s important for new investors to understand that guidance can be a significant driver of stock prices.
Historical Earnings Performance
The company’s EPS missed by $0.21 in the …